Silverarc Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-111,000
| Closed | -$3.84M | – | 61 |
|
|
2025
Q1 | $3.84M | Buy |
+111,000
| New | +$3.84M | 0.78% | 31 |
|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$860K | – | 72 |
|
|
2023
Q2 | $860K | Buy |
50,000
+10,000
| +25% | +$172K | 0.27% | 58 |
|
|
2023
Q1 | $663K | Buy |
+40,000
| New | +$663K | 0.27% | 56 |
|
|
2022
Q1 | – | Sell |
-100,000
| Closed | -$1.67M | – | 67 |
|
|
2021
Q4 | $1.67M | Buy |
+100,000
| New | +$1.67M | 0.68% | 43 |
|